Patrick F. Kiser - Publications

Bioengineering University of Utah, Salt Lake City, UT 
Biomedical Engineering, Virology Biology, Public Health

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Karunakaran D, Simpson SM, Su JT, Bryndza-Tfaily E, Hope TJ, Veazey R, Dobek G, Qiu J, Watrous D, Sung S, Chacon JE, Kiser PF. Design and testing of a cabotegravir implant for HIV prevention. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33347943 DOI: 10.1016/j.jconrel.2020.12.024  0.36
2018 Calder BJ, Schieffer RJ, Bryndza Tfaily E, D'Aquila RT, Greene G, Carballo-Diéguez A, Giguere R, Kiser PF, Hope TJ. Qualitative Consumer Research on Acceptance of Long-acting PrEP Products among MSM and Medical Practitioners in the United States. Aids Research and Human Retroviruses. PMID 30229684 DOI: 10.1089/Aid.2018.0214  0.36
2018 Thurman AR, Schwartz JL, Brache V, Clark MR, McCormick T, Chandra N, Marzinke MA, Stanczyk FZ, Dezzutti CS, Hillier SL, Herold BC, Fichorova R, Asin SN, Rollenhagen C, Weiner D, ... Kiser P, et al. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women. Plos One. 13: e0199778. PMID 29953547 DOI: 10.1371/Journal.Pone.0199778  0.6
2017 Schneider JR, Carias AM, Bastian AR, Cianci GC, Kiser PF, Veazey RS, Hope TJ. Long-term direct visualization of passively transferred fluorophore-conjugated antibodies. Journal of Immunological Methods. PMID 28780040 DOI: 10.1016/J.Jim.2017.07.009  0.36
2017 Srinivasan P, Zhang J, Dinh CT, Teller RS, McNicholl JM, Kiser PF, Herold BC, Smith JM. Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings. Journal of Medical Primatology. 46: 129-136. PMID 28748662 DOI: 10.1111/Jmp.12299  0.36
2016 Greene GJ, Swann G, Fought AJ, Carballo-Diéguez A, Hope TJ, Kiser PF, Mustanski B, D'Aquila RT. Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men. Aids and Behavior. PMID 27770215 DOI: 10.1007/S10461-016-1565-9  0.6
2016 Carias AM, Allen SA, Fought AJ, Kotnik Halavaty K, Anderson MR, Jimenez ML, McRaven MD, Gioia CJ, Henning TR, Kersh EN, Smith JM, Pereira LE, Butler K, McNicholl SJ, Hendry RM, ... Kiser PF, et al. Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract. Plos Pathogens. 12: e1005885. PMID 27658293 DOI: 10.1371/Journal.Ppat.1005885  0.6
2016 Gunn BM, Schneider JR, Shansab M, Bastian AR, Fahrbach KM, Smith AD, Mahan AE, Karim MM, Licht AF, Zvonar I, Tedesco J, Anderson MR, Chapel A, Suscovich TJ, Malaspina DC, ... ... Kiser PF, et al. Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16. Mucosal Immunology. PMID 26960182 DOI: 10.1038/Mi.2016.8  0.6
2016 Guthrie KM, Dunsiger S, Vargas S, Fava JL, Shaw JG, Rosen RK, Kiser PF, Kojic EM, Friend DR, Katz D. Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design. Aids Research and Human Retroviruses. PMID 26942455 DOI: 10.1089/Aid.2015.0275  0.36
2015 Teller RS, Malaspina DC, Rastogi R, Clark JT, Szleifer I, Kiser PF. Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral release. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26723526 DOI: 10.1016/J.Jconrel.2015.12.035  0.6
2015 Taneva E, Crooker K, Park SH, Su JT, Ott A, Cheshenko N, Szleifer I, Kiser PF, Frank B, Mesquita PM, Herold BC. Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Pre-exposure Prophylaxis. Antimicrobial Agents and Chemotherapy. PMID 26711762 DOI: 10.1128/Aac.02793-15  0.6
2015 Morrow Guthrie K, Vargas S, Shaw JG, Rosen RK, van den Berg JJ, Kiser PF, Buckheit K, Bregman D, Thompson L, Jensen K, Johnson T, Buckheit RW. The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development. Plos One. 10: e0145642. PMID 26695431 DOI: 10.1371/Journal.Pone.0145642  0.6
2015 Keller MJ, Mesquita PM, Marzinke MA, Teller R, Espinoza L, Atrio JM, Lo Y, Frank B, Srinivasan S, Fredricks DN, Rabe L, Anderson PL, Hendrix CW, Kiser PF, Herold BC. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring. Aids (London, England). PMID 26605514 DOI: 10.1097/Qad.0000000000000979  0.6
2015 Rastogi R, Su J, Mahalingam A, Clark J, Sung S, Hope T, Kiser PF. Engineering and Characterization of Simplified Vaginal and Seminal Fluid Simulants. Contraception. PMID 26585883 DOI: 10.1016/J.Contraception.2015.11.008  0.6
2015 Seay K, Khajoueinejad N, Zheng JH, Kiser P, Ochsenbauer C, Kappes JC, Herold B, Goldstein H. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment. Journal of Virology. 89: 9559-70. PMID 26157126 DOI: 10.1128/Jvi.01326-15  0.6
2015 Ugaonkar SR, Clark JT, English LB, Johnson TJ, Buckheit KW, Bahde RJ, Appella DH, Buckheit RW, Kiser PF. An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission. Journal of Pharmaceutical Sciences. 104: 3426-39. PMID 26149293 DOI: 10.1002/Jps.24551  0.6
2015 Chen S, Yi J, Dong B, Sun C, Kiser PF, Hope TJ, Zhang HF. Imaging endocervical mucus anatomy and dynamics in macaque female reproductive track using optical coherence tomography. Quantitative Imaging in Medicine and Surgery. 5: 40-5. PMID 25694952 DOI: 10.3978/J.Issn.2223-4292.2014.11.03  0.36
2015 Smith JM, Srinivasan P, Teller RS, Lo Y, Dinh CT, Kiser PF, Herold BC. Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 1-5. PMID 25321184 DOI: 10.1097/Qai.0000000000000402  0.6
2015 Smith JM, Srinivasan P, Teller RS, Lo Y, Dinh CT, Kiser PF, Herold BC. Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures Journal of Acquired Immune Deficiency Syndromes. 68: 1-5.  0.6
2014 Srinivasan P, Dinh C, Zhang J, Pau CP, McNicholl JM, Lo Y, Herold BC, Teller R, Kiser P, Smith JM. Pharmacokinetic evaluation of tenofovir disoproxil fumarate released from an intravaginal ring in pigtailed macaques after 6 months of continuous use. Journal of Medical Primatology. 43: 364-9. PMID 25379594 DOI: 10.1111/Jmp.12119  0.6
2014 Teller RS, Rastogi R, Johnson TJ, Blair MJ, Hitchcock RW, Kiser PF. Intravaginal flux controlled pump for sustained release of macromolecules. Pharmaceutical Research. 31: 2344-53. PMID 24789449 DOI: 10.1007/S11095-014-1331-5  0.6
2014 Clark JT, Clark MR, Shelke NB, Johnson TJ, Smith EM, Andreasen AK, Nebeker JS, Fabian J, Friend DR, Kiser PF. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy. Plos One. 9: e88509. PMID 24599325 DOI: 10.1371/Journal.Pone.0088509  0.6
2014 Nixon B, Jandl T, Teller RS, Taneva E, Wang Y, Nagaraja U, Kiser PF, Herold BC. Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety. Antimicrobial Agents and Chemotherapy. 58: 1153-60. PMID 24323471 DOI: 10.1128/Aac.01818-13  0.6
2014 van den Berg JJ, Rosen RK, Bregman DE, Thompson LA, Jensen KM, Kiser PF, Katz DF, Buckheit K, Buckheit RW, Morrow KM. "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels. Aids and Behavior. 18: 862-70. PMID 24248674 DOI: 10.1007/S10461-013-0652-4  0.6
2014 Morrow KM, Fava JL, Rosen RK, Vargas S, Shaw JG, Kojic EM, Kiser PF, Friend DR, Katz DF. Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. Aids Research and Human Retroviruses. 30: 78-91. PMID 24180360 DOI: 10.1089/AID.2013.0099  0.6
2013 Friend DR, Clark JT, Kiser PF, Clark MR. Multipurpose prevention technologies: products in development. Antiviral Research. 100: S39-47. PMID 24188708 DOI: 10.1016/J.Antiviral.2013.09.030  0.6
2013 Mesquita PM, Srinivasan P, Johnson TJ, Rastogi R, Evans-Strickfaden T, Kay MS, Buckheit KW, Buckheit RW, Smith JM, Kiser PF, Herold BC. Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties. Retrovirology. 10: 113. PMID 24156604 DOI: 10.1186/1742-4690-10-113  0.6
2013 Smith JM, Rastogi R, Teller RS, Srinivasan P, Mesquita PM, Nagaraja U, McNicholl JM, Hendry RM, Dinh CT, Martin A, Herold BC, Kiser PF. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Proceedings of the National Academy of Sciences of the United States of America. 110: 16145-50. PMID 24043812 DOI: 10.1073/Pnas.1311355110  0.6
2013 Rastogi R, Teller RS, Mesquita PM, Herold BC, Kiser PF. Osmotic pump tablets for delivery of antiretrovirals to the vaginal mucosa. Antiviral Research. 100: 255-8. PMID 23973812 DOI: 10.1016/J.Antiviral.2013.08.007  0.6
2013 Friend DR, Kiser PF. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antiviral Research. 99: 391-400. PMID 23845918 DOI: 10.1016/J.Antiviral.2013.06.021  0.6
2013 Shukair SA, Allen SA, Cianci GC, Stieh DJ, Anderson MR, Baig SM, Gioia CJ, Spongberg EJ, Kauffman SM, McRaven MD, Lakougna HY, Hammond C, Kiser PF, Hope TJ. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunology. 6: 427-34. PMID 22990624 DOI: 10.1038/Mi.2012.87  0.6
2012 Johnson TJ, Clark MR, Albright TH, Nebeker JS, Tuitupou AL, Clark JT, Fabian J, McCabe RT, Chandra N, Doncel GF, Friend DR, Kiser PF. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Antimicrobial Agents and Chemotherapy. 56: 6272-83. PMID 23006751 DOI: 10.1128/Aac.01431-12  0.6
2012 Clark JT, Johnson TJ, Clark MR, Nebeker JS, Fabian J, Tuitupou AL, Ponnapalli S, Smith EM, Friend DR, Kiser PF. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 240-8. PMID 22981701 DOI: 10.1016/J.Jconrel.2012.08.033  0.6
2012 Kiser PF, Mesquita PM, Herold BC. A perspective on progress and gaps in HIV prevention science. Aids Research and Human Retroviruses. 28: 1373-8. PMID 22966871 DOI: 10.1089/Aid.2012.0277  0.6
2012 Mesquita PM, Rastogi R, Segarra TJ, Teller RS, Torres NM, Huber AM, Kiser PF, Herold BC. Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. The Journal of Antimicrobial Chemotherapy. 67: 1730-8. PMID 22467632 DOI: 10.1093/Jac/Dks097  0.6
2012 Kiser PF, Mahalingam A, Fabian J, Smith E, Damian FR, Peters JJ, Katz DF, Elgendy H, Clark MR, Friend DR. Design of tenofovir-UC781 combination microbicide vaginal gels. Journal of Pharmaceutical Sciences. 101: 1852-64. PMID 22359356 DOI: 10.1002/Jps.23089  0.6
2012 Kiser PF, Johnson TJ, Clark JT. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. Aids Reviews. 14: 62-77. PMID 22297505  0.6
2012 Ham AS, Ugaonkar SR, Shi L, Buckheit KW, Lakougna H, Nagaraja U, Gwozdz G, Goldman L, Kiser PF, Buckheit RW. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection. Journal of Pharmaceutical Sciences. 101: 1423-35. PMID 22227864 DOI: 10.1002/Jps.23026  0.6
2012 Johnson TJ, Srinivasan P, Albright TH, Watson-Buckheit K, Rabe L, Martin A, Pau CP, Hendry RM, Otten R, McNicholl J, Buckheit R, Smith J, Kiser PF. Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings. Antimicrobial Agents and Chemotherapy. 56: 1291-9. PMID 22155820 DOI: 10.1128/Aac.05721-11  0.6
2012 Clark MR, Johnson TJ, McCabe RT, Clark JT, Tuitupou A, Elgendy H, Friend DR, Kiser PF. A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781. Journal of Pharmaceutical Sciences. 101: 576-87. PMID 21976110 DOI: 10.1002/Jps.22781  0.6
2011 Clark MR, Kiser PF, Loxley A, McConville C, Malcolm RK, Friend DR. Pharmacokinetics of UC781-loaded intravaginal ring segments in rabbits: a comparison of polymer matrices. Drug Delivery and Translational Research. 1: 238-46. PMID 25788242 DOI: 10.1007/S13346-011-0032-4  0.6
2011 Kaur M, Gupta KM, Poursaid AE, Karra P, Mahalingam A, Aliyar HA, Kiser PF. Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine. Drug Delivery and Translational Research. 1: 223-37. PMID 25788241 DOI: 10.1007/S13346-011-0027-1  0.6
2011 Mahalingam A, Geonnotti AR, Balzarini J, Kiser PF. Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry. Molecular Pharmaceutics. 8: 2465-75. PMID 21879735 DOI: 10.1021/Mp2002957  0.6
2011 Mahalingam A, Jay JI, Langheinrich K, Shukair S, McRaven MD, Rohan LC, Herold BC, Hope TJ, Kiser PF. Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system. Biomaterials. 32: 8343-55. PMID 21875751 DOI: 10.1016/J.Biomaterials.2011.05.001  0.6
2011 Clark MR, Aliyar HA, Lee CW, Jay JI, Gupta KM, Watson KM, Stewart RJ, Buckheit RW, Kiser PF. Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles. International Journal of Pharmaceutics. 413: 10-18. PMID 21511017 DOI: 10.1016/J.Ijpharm.2011.04.004  0.6
2011 Mahalingam A, Simmons AP, Ugaonkar SR, Watson KM, Dezzutti CS, Rohan LC, Buckheit RW, Kiser PF. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Antimicrobial Agents and Chemotherapy. 55: 1650-60. PMID 21245437 DOI: 10.1128/Aac.01368-10  0.6
2011 Jay JI, Langheinrich K, Hanson MC, Mahalingam A, Kiser PF. Unequal stoichiometry between crosslinking moieties affects the properties of transient networks formed by dynamic covalent crosslinks Soft Matter. 7: 5826-5835. DOI: 10.1039/C1Sm05209H  0.6
2010 Malcolm RK, Edwards KL, Kiser P, Romano J, Smith TJ. Advances in microbicide vaginal rings. Antiviral Research. 88: S30-9. PMID 21109066 DOI: 10.1016/J.Antiviral.2010.09.003  0.6
2010 Mahalingam A, Smith E, Fabian J, Damian FR, Peters JJ, Clark MR, Friend DR, Katz DF, Kiser PF. Design of a semisolid vaginal microbicide gel by relating composition to properties and performance. Pharmaceutical Research. 27: 2478-91. PMID 20842411 DOI: 10.1007/S11095-010-0244-1  0.6
2010 Damian F, Fabian J, Friend DR, Kiser PF. Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions. International Journal of Pharmaceutics. 396: 1-10. PMID 20510342 DOI: 10.1016/J.Ijpharm.2010.05.024  0.6
2010 Jay JI, Lai BE, Myszka DG, Mahalingam A, Langheinrich K, Katz DF, Kiser PF. Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors. Molecular Pharmaceutics. 7: 116-29. PMID 20014858 DOI: 10.1021/Mp900159N  0.6
2010 Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 39: 203-12. PMID 19958831 DOI: 10.1016/J.Ejps.2009.11.007  0.6
2010 Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF. Corrigendum to "Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir" [Eur. J. Pharm. Sci. 39 (2010) 203-212] European Journal of Pharmaceutical Sciences. 41: 736. DOI: 10.1016/J.Ejps.2010.09.010  0.6
2009 Jay JI, Shukair S, Langheinrich K, Hanson MC, Cianci GC, Johnson TJ, Clark MR, Hope TJ, Kiser PF. Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel. Advanced Functional Materials. 19: 2969-2977. PMID 23101003 DOI: 10.1002/Adfm.200900757  0.6
2009 Clark M, Kiser P. In situ crosslinked hydrogels formed using Cu(I)-free Huisgen cycloaddition reaction Polymer International. 58: 1190-1195. DOI: 10.1002/Pi.2650  0.6
2009 Gupta KM, Pearce SM, Poursaid AE, Aliyar HA, Tresco PA, Mitchnik MA, Kiser PF. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1 (Journal of Pharmaceutical Sciences (2008) 97, (4228-4239)) Journal of Pharmaceutical Sciences. 98: 1199. DOI: 10.1002/Jps.21700  0.6
2009 Gupta KM, Barnes SR, Tangaro RA, Roberts MC, Owen DH, Katz DF, Kiser PF. Temperature and pH sensitive hydrogels: An approach towards smart semen-triggered vaginal microbicidal vehicles (Journal of Pharmaceutical Sciences (2007) 96, (670-681)) Journal of Pharmaceutical Sciences. 98: 1198. DOI: 10.1002/Jps.21699  0.6
2009 Li J, Kulshrestha AS, Fang Z, Pedersen S, Katsarava R, McKennon M, Kenmoku T, Luo L. Medical Polymers: Biomaterials for Drug Delivery Devices Patent Applications: a Tool For Identifying Advances in Polymer Chemistry R & D. 455-488. DOI: 10.1002/9780470507315.ch14  0.6
2008 Roberts MC, Mahalingam A, Hanson MC, Kiser PF. Chemorheology of phenylboronate-salicylhydroxamate crosslinked hydrogel networks with a sulfonated polymer backbone. Macromolecules. 41: 8832-8840. PMID 23132956 DOI: 10.1021/Ma8012674  0.6
2008 Gupta KM, Pearce SM, Poursaid AE, Aliyar HA, Tresco PA, Mitchnik MA, Kiser PF. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. Journal of Pharmaceutical Sciences. 97: 4228-39. PMID 18338805 DOI: 10.1002/Jps.21331  0.6
2008 Geonnotti AR, Furlow MJ, Wu T, DeSoto MG, Henderson MH, Kiser PF, Katz DF. Measuring macrodiffusion coefficients in microbicide hydrogels via postphotoactivation scanning. Biomacromolecules. 9: 748-51. PMID 18193840 DOI: 10.1021/Bm701018W  0.6
2008 Jay JI, Roberts MC, Hanson MC, Kiser PF. PH responsive phenylboronate-salicylhydroxamate crosslinked hydrogels for STD prevention American Chemical Society, Polymer Preprints, Division of Polymer Chemistry. 49: 1043-1044.  0.6
2007 Gupta KM, Barnes SR, Tangaro RA, Roberts MC, Owen DH, Katz DF, Kiser PF. Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles. Journal of Pharmaceutical Sciences. 96: 670-81. PMID 17154368 DOI: 10.1002/Jps.20752  0.6
2007 Roberts MC, Hanson MC, Massey AP, Karren EA, Kiser PF. Dynamically restructuring hydrogel networks formed with reversible covalent crosslinks Advanced Materials. 19: 2503-2507. DOI: 10.1002/Adma.200602649  0.6
2006 Endrizzi BJ, Huang G, Kiser PF, Stewart RJ. Specific covalent immobilization of proteins through dityrosine cross-links. Langmuir : the Acs Journal of Surfaces and Colloids. 22: 11305-10. PMID 17154619 DOI: 10.1021/La0618216  0.6
2005 Stayner RS, Min DJ, Kiser PF, Stewart RJ. Site-specific cross-linking of proteins through tyrosine hexahistidine tags. Bioconjugate Chemistry. 16: 1617-23. PMID 16287262 DOI: 10.1021/Bc050249B  0.6
2005 Eichenbaum KD, Thomas AA, Eichenbaum GM, Gibney BR, Needham D, Kiser PF. Oligo-α-hydroxy ester cross-linkers: Impact of cross-linker structure on biodegradable hydrogel networks Macromolecules. 38: 10757-10762. DOI: 10.1021/Ma0518306  0.6
2005 Thomas AA, Kim IT, Kiser PF. Symmetrical biodegradable crosslinkers for use in polymeric devices Tetrahedron Letters. 46: 8921-8925. DOI: 10.1016/J.Tetlet.2005.10.066  0.6
2001 Kiser PF, Collupy GC, Eichenbaum GM, Rush C, Baumann S, Kust MP, Greaves MD, Frederick ED, Soltmann B, Vasina H, Orji C, Bienfiat B, Brown JD, Davies J, Atkins M, et al. Engineering An Experimental Platform for High Throughput Reactivity Screening Jala - Journal of the Association For Laboratory Automation. 6: XXIV-XXV. DOI: 10.1016/S1535-5535(04)00172-8  0.6
2000 Kiser PF, Wilson G, Needham D. Lipid-coated microgels for the triggered release of doxorubicin. Journal of Controlled Release : Official Journal of the Controlled Release Society. 68: 9-22. PMID 10884575 DOI: 10.1016/S0168-3659(00)00236-4  0.6
2000 Oortgiesen M, Veronesi B, Eichenbaum G, Kiser PF, Simon SA. Residual oil fly ash and charged polymers activate epithelial cells and nociceptive sensory neurons. American Journal of Physiology. Lung Cellular and Molecular Physiology. 278: L683-95. PMID 10749745 DOI: 10.1152/Ajplung.2000.278.4.L683  0.6
2000 Eichenbaum GM, Kiser PF, Shah D, Meuer WP, Needham D, Simon SA. Alkali earth metal binding properties of ionic microgels Macromolecules. 33: 4087-4093. DOI: 10.1021/Ma9917139  0.6
2000 Kiser PF, Thomas AA, Eichenbaum GM, Needham D, Kim I. Design and performance of poly(HPMA) hydrogels containing symmetrical biodegradable crosslinkers composed of oligo-lactate and oligo-glycolate esters American Chemical Society, Polymer Preprints, Division of Polymer Chemistry. 41: 712-713.  0.6
1999 Eichenbaum GM, Kiser PF, Shah D, Simon SA, Needham D. Investigation of the swelling response and drug loading of ionic microgels: The dependence on functional group composition Macromolecules. 32: 8996-9006. DOI: 10.1021/Ma9908393  0.6
1999 Eichenbaum GM, Kiser PF, Dobrynin AV, Simon SA, Needham D. Investigation of the swelling response and loading of ionic microgels with drugs and proteins: the dependence on cross-link density Macromolecules. 32: 4867-4878. DOI: 10.1021/Ma981945S  0.6
1998 Kiser PF, Wilson G, Needham D. A synthetic mimic of the secretory granule for drug delivery. Nature. 394: 459-62. PMID 9697768 DOI: 10.1038/28822  0.6
1998 Eichenbaum GM, Kiser PF, Simon SA, Needham D. pH and ion-triggered volume response of anionic hydrogel microspheres Macromolecules. 31: 5084-5093.  0.6
1992 Ames JR, Kovacic P, Kadaba PK, Kiser PF. Electrochemistry of anticonvulsants: electron transfer as a possible mode of action. Epilepsia. 33: 936-43. PMID 1396439 DOI: 10.1111/j.1528-1157.1992.tb02204.x  0.6
1991 Kovacic P, Kiser PF, Reger DL, Huff MF, Feinberg BA. Electrochemistry of Cu(I) bipyridyl complexes with alkene, alkyne, and nitrile ligands. Implications for plant hormone action of ethylene. Free Radical Research Communications. 15: 143-9. PMID 1773940 DOI: 10.3109/10715769109049134  0.6
1991 Kovacic P, Kiser PF, Smith KM, Feinberg BA. Spectroelectrochemical titrations and cyclic voltammetry of methyl pheophorbide in acid: Possible role of pheophytin enol iminium in the primary process of PS II Bioelectrochemistry and Bioenergetics. 25: 415-424. DOI: 10.1016/0302-4598(91)80006-O  0.6
1990 Kovacic P, Edwards WD, Natale NR, Sridhar R, Kiser PF. Theoretical calculations on calcium channel drugs: is electron transfer involved mechanistically? Chemico-Biological Interactions. 75: 61-70. PMID 2364458 DOI: 10.1016/0009-2797(90)90022-F  0.6
1990 Kovacic P, Kiser PF, Feinberg BA. Are reduction potentials of antifungal agents relevant to activity? Pharmaceutical Research. 7: 283-8. PMID 2339103 DOI: 10.1023/A:1015834431140  0.6
Show low-probability matches.